Stock Events

Stock Events

HLS Therapeutics (74D.F) Q3 2025 Earnings

14AugConfirmed

Q4 2024

Q1 2025

Q2 2025

Q3 2025

-0.14

-0.11

-0.09

-0.06

Details

Expected EPS

-0.06414781788

Actual EPS

-0.0772524

Surprise EPS

-0.01

Surprise Percent

+20.43%

Description

HLS Therapeutics (74D.F) has reported earnings of -0.0772524 per share for Q3 2025.

0 Comments

Share your thoughts

Get the Stock Events App

Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.